Categories: Lymphoma

Stem Cell Transplant Benefit Limited for Some Patients With Lymphoma

There is currently no uniform procedure for patients with double-hit lymphoma (DHL) that prolongs benefit. Some patients receive autologous ...

Copanlisib was granted a priority review designation by the Food and Drug Administratioin (FDA) for the treatment of patients with relapsed/...

For patients with chronic lymphocytic leukemia (CLL) who developed Hodgkin lymphoma (HL) after the Richter transformation, achieving a compl...

There were nearly identical response rates and toxicity with subcutaneous administration of Rituxan (rituximab) and IV administration of the...

Oncologists are currently facing difficulty finding prognostic factors for developing mantle cell lymphoma (MCL), but researcher are conduct...

Valosin-containing protein – p97 – is crucial in restoring the homeostasis of cancer cells. When working alongside the ubiquitin...

By using current combinations, investigators are working on novel approaches for the frontline and relapsed/refractory settings to treat pat...

According to a recent study presented at the 2017 annual meeting of the American Association for Cancer Research, the number of cancer cases...

For patients with hematologic malignancies, promise lies in the immunotherapy technique of adoptive cell transfer (ACT). The building blocks...

Some women with breast implants may be at risk for developing a rare type of lymphoma, according to a recent statement released by the Food ...